Concepedia

Yunfeng Li

YL

Statistics

Publications

16

Citations

1.1K

H-Index

16

Active since

2013

Affiliations

Kunming Medical University(Current)

AntiCancer (United States)

University of California, Los Angeles

University of California San Diego

Tohoku University

Yunfeng Li is an author at Kunming Medical University specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2013–2022

16

Publications

16

Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice

Weixing Zhao, Zhipeng Xu, Jiangbei Cao et al. · Journal of Neuroinflammation · 2019 · 207 citations · Full text

, , +17

Circ_0026344 restrains metastasis of human colorectal cancer cells via miR-183

Tao Shen, Xianshuo Cheng, Xin Liu et al. · Artificial Cells Nanomedicine and Biotechnology · 2019 · 104 citations · Full text

, , +17

CXCL8, overexpressed in colorectal cancer, enhances the resistance of colorectal cancer cells to anoikis

Youchuan Xiao, Zhibin Yang, Xianshuo Cheng et al. · Cancer Letters · 2015 · 102 citations

, , +14

Recombinant methioninase effectively targets a Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model

Takashi Murakami, Shukuan Li, Qinghong Han et al. · Oncotarget · 2017 · 81 citations · Full text

, , +7

Vemurafenib-resistant BRAF-V600E-mutated melanoma is regressed by MEK-targeting drug trametinib, but not cobimetinib in a patient-derived orthotopic xenograft (PDOX) mouse model

Kei Kawaguchi, Takashi Murakami, Bartosz Chmielowski et al. · Oncotarget · 2016 · 74 citations · Full text

, , +15

1–5 of 16